USPTO 2015–2025 USPTO PatentsView US Corporation

Tampro Inc.

USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tampro ranks #43,498 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 1 technology areas.

#43,498
of 49,997 US assignees by volume
43rd percentile
by Innovation Score (32.9/100)
4.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R43498 · US Corporation #43,498 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 6 grants
  • LOWER-Q #43,498/49,997
  • PHOTO-FINISH Takazono
  • CPC-NARROW A61F · 1 areas
  • INNOV-THIN 32.9/100
  • CLAIMS-SPARSE 4.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Takazono Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Tampro

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tampro's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Tampro's grants concentrate

Tampro Inc. is a focused PatentsView assignee: 1 CPC subclasses with 16.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2021. By volume, Tampro sits between Takazono Corporation and Tangentix Limited.

Tampro's three-year grant acceleration

Tampro Inc. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tampro's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tampro holds 6 patents at rank #43,461, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tampro

By rank, the assignees closest to #43,461 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Tampro's primary technology class.

Tampro's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2021202320242025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Tampro Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 16.7%
2023 1 16.7%
2024 3 50.0%
2025partial year 1 16.7%

Where it ranks

Overall rank by patents

#43,498

of 49,997 tracked assignees

Innovation Score

32.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Tampro Inc.'s patent record in context - here's where to go next.

  • Tampro Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 16.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #43,498 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tampro Inc. against Takazono Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.